MRNA
Moderna, Inc.Close $48.12EOD onlyThis page reflects MRNA options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.
Consensus-supported lens with chain history and key metrics in the rail.
Outlook
Neutral-to-bearish with a short-term pinning magnet toward $51-$52, but a clear structural downtrend in max pain suggests underlying weakness. Confidence: 5/10. The regime is conflicted: positive GEX supports a pin, but net negative premium flow and a falling MP ladder point to selling pressure.
Conflicts: Net premium -$49.4M (bearish), max pain ladder falls from $52 to $35 long-term, IV >80% obscures directional signals.
Regime Classification
Price Range Forecast
Key Levels
Dealer Positioning (GEX/DEX)
GEX: $+28.9M
DEX: +23.9M shares
Gamma flip: ~$25 (Approx โ based on put OI concentration of 16,149)
NTM gamma: Gamma flip ~$25 is irrelevant near-term; positive GEX from calls near $50-$53 drives pinning. A move below $48.5 would reduce pinning pressure; a move above $53 would accelerate dealer short-covering.
IV Analysis
IV vs VIX: IV 81.3% โ extremely elevated vs typical biotech/historical, offering rich premium for sellers.
Term structure: Humped โ peaks at May expirations (~75%), then flattens. Kink at 5/01 (72.4%) likely pricing April 30 earnings.
Skew: Extreme skew in long-dated, deep OTM puts (e.g., Dec '26 $85 Put IV 205%) โ potential for ratio spreads selling those strikes vs buying nearer-dated puts.
Flow Analysis
Net premium: -$49.4M bearish; P/C vol 0.85, P/C OI 0.99.
Directional prints: $53C 3/27 vol 155 vs OI 16,178 โ likely closing/selling against existing long OI. $40P vol 104 vs OI 14,290 โ could be rolling or closing.
Unusual: **Deep OTM Put Sales**: Massive premium in Dec '26 $85P ($16.5M) and $135P ($7.1M) โ likely institutional tail-risk hedging or financing trades, not directional.
Risks & Catalysts
Strategy Viability
| Strategy | Edge | Best Setup | Primary Risk |
|---|---|---|---|
| Long stock | Weak | N/A | Bearish MP trend and negative net flow oppose. |
| Short stock | Moderate-Weak | N/A | Near-term pinning creates headwinds; better expressed via options. |
| Covered call | Moderate-Strong | Own stock, sell $53C or $55C 4/10 or 4/17. | Stock pinned below strike; upside capped. |
| Cash-secured put / put spread | Moderate-Strong | Sell $45/$40 put spread 4/17 (below 1w EM low). | Break of pin below $46.24. |
| Long calls | Weak | N/A | High IV expensive; pinning limits upside. |
| Long puts / bear put spread | Moderate | Buy $50/$45 put spread 4/17 or 5/01 (earnings). | Pinning eats theta; need break below $48.5. |
| Iron condor | Moderate | $45P/$40P x $53C/$56C 4/17 (outside 1w EM bounds). | GEX positive but VIX proxy (IV) >28, and range is wide. |
| Calendar/diagonal | Moderate | Sell 5/01 $51C (IV 72.4%), buy 4/17 $51C (IV 66.0%) โ reverse calendar for pin breakdown. | Pin holds through April expiry. |
| PMCC / LEAPS diagonal | Moderate | Buy Jan '27 $35C, sell Apr/May $51-$53 calls against it. | Long-dated IV still high; capital intensive. |
Top Plays
Watchlist Triggers
Tactical Summary
Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.
Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.
These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.